Optimising human small intestinal organoids by implementing Paneth cells
Researchers have succeeded in developing organoids that contain mature Paneth cells, which were not present in the previous human small intestinal organoids.
List view / Grid view
Researchers have succeeded in developing organoids that contain mature Paneth cells, which were not present in the previous human small intestinal organoids.
The drug candidate, JSF-2659, has been developed to be administered orally, and could be a game changer in treating gonorrhoea.
The findings by Massachusetts General Hospital could point to a potential target to treat Crohn’s disease.
An animal study has shown that a modified vaccine for tuberculosis could treat bladder cancer whilst minimising side effects.
Scientists have identified and synthesised a small molecule that could be a more accessible and affective alternative to an antibody that treats a wide range of cancers.
The new RSV vaccine formulation protected newborn mice against infection and evoked strong responses in immune cells from human newborns.
Researchers found that fibroblasts had varying effects on tumour cells based on both the type of non-small cell lung cancer and the drug used for treatment.
A novel peptide augments the brain’s natural mechanism to help prevent seizures and protect neurons in research models of both Alzheimer’s and epilepsy.
Researchers have developed an mRNA-based cancer vaccine that is delivered directly into the lymphatic system for a more potent response.
This publications review overviews advanced flow cytometry applications in infectious disease and immuno-oncology.
Learn about current and emerging immune checkpoint molecules that are being investigated as potential immuno-oncology targets.
12 August 2022 | By
A new technique could relieve pain for individuals with various chronic and neurological conditions.
This guide highlights the four major stages of TPD, the challenges at each step and questions you should ask yourself.
Researchers have developed a needle-free mucosal bacteriophage (phage) T4-based COVID-19 vaccine is effective against SARS-CoV-2 infection.
Using computational methods, researchers analysed the most popular CRISPR library designed for human cells and found 3,300 targeted spots that show strong toxic effects.